BioRestorative Therapies to announce 2024 financial results

BioRestorative Therapies, Inc., a company that focuses on regenerative medicine, will announce its financial results for 2024 on March 27, 2025, after the stock market closes. Following the results announcement, company management will hold a conference call at 4:30 p.m. ET. People can join the call by dialing 1-888-506-0062 for domestic calls and 1-973-528-0011 for international callers. The call will also be available to listen live on the company's website. BioRestorative specializes in therapies that use stem cells. They are working on two main programs: one for treating spine and disc diseases, and another for addressing obesity and metabolic disorders. Their BRTX-100 cell therapy aims to help patients with chronic lower back pain caused by degenerative disc disease. Additionally, the company has a BioCosmeceutical line that uses cell-based products for cosmetic enhancements. They are developing a serum to reduce wrinkles and may expand into other aesthetic products in the future. Investors are advised to consider potential risks when looking at forward-looking statements made by the company.